AWIIX
Price
$15.32
Change
+$0.14 (+0.92%)
Updated
Apr 24 closing price
Net Assets
656.16M
RLBCX
Price
$33.48
Change
+$0.43 (+1.30%)
Updated
Apr 24 closing price
Net Assets
226.9B
Ad is loading...

AWIIX vs RLBCX

Header iconAWIIX vs RLBCX Comparison
Open Charts AWIIX vs RLBCXBanner chart's image
CIBC Atlas Income Opportunities Instl
Price$15.32
Change+$0.14 (+0.92%)
VolumeN/A
Net Assets656.16M
American Funds American Balanced R3
Price$33.48
Change+$0.43 (+1.30%)
VolumeN/A
Net Assets226.9B
AWIIX vs RLBCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AWIIX vs. RLBCX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AWIIX is a Buy and RLBCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 227B vs. AWIIX (656M). AWIIX pays higher dividends than RLBCX: AWIIX (1.80) vs RLBCX (1.69). AWIIX was incepted earlier than RLBCX: AWIIX (11 years) vs RLBCX (23 years). RLBCX (0.89) is less costly to investors than AWIIX (0.69). RLBCX is a more actively managed with annual turnover of: 171.00 vs. AWIIX (19.00). RLBCX has a lower initial minimum investment than AWIIX: RLBCX (250) vs AWIIX (250000). RLBCX annual gain was more profitable for investors over the last year : 3.84 vs. AWIIX (2.72). AWIIX return over 5 years is better than : 46.11 vs. RLBCX (33.97).
AWIIXRLBCXAWIIX / RLBCX
Total Expense Ratio0.690.8978%
Annual Report Gross Expense Ratio0.690.8978%
Fund Existence11 years23 years-
Gain YTD-3.312-1.616205%
Front LoadN/AN/A-
Min. Initial Investment250000250100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets656M227B0%
Annual Yield % from dividends1.801.69106%
Returns for 1 year2.723.8471%
Returns for 3 years10.4913.6077%
Returns for 5 years46.1133.97136%
Returns for 10 years85.1344.52191%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WES39.171.27
+3.35%
Western Midstream Partners LP
UNB35.730.70
+2.00%
Union Bankshares
EVER23.210.44
+1.93%
EverQuote
XAGE0.16N/A
-2.44%
Longevity Health Holdings Inc
PTGX44.85-1.31
-2.84%
Protagonist Therapeutics